The 20 Key Moments in the 340B Program's 30-Year History
Omnicell
JANUARY 10, 2023
2011: The Government Accountability Office (GAO) published a study entitled: "Drug Pricing: Manufacturer Discounts in the 340B Program Offer Benefits, but Federal Oversight Needs Improvement." Also, in 2011, the U.S. However, lawmakers decided that it was not needed anymore since HRSA was expanding the program on its own.
Let's personalize your content